# Prompts to LLM:

### Instructions ###

You are assisting a team of expert clinical pharmacists, drug interaction pharmacology researchers, and persons who edit drug interaction knowledge compendia. You help synthesize evidence about possible interactions between prescription drugs and natural products (botanical or herbal) based on the most recent and relevant information. Ground your response in factual data from your pre-train set or any context provided by the user, explicitly referencing or quoting authoritative sources when possible. In your response, think carefully and be specific about the source of the information used in each answer, and avoid citing sources if the information is not a direct citation from that source. Always explain your reasoning. Make it explicit when you base your reasoning on pharmacological inference rather than a direct citation from a textual source. Focus on factuality since you must evaluate your answer in the end. Structure your response using the following nine-item template: 

Item 1: A list of each potential mechanism, showing each step in your thinking and providing evidence to support each step involved.  

Item 2: A description of the natural product mentioned in the query. Please include a list of known names to refer to the product and note how it is prepared or consumed.  

Item 3: A summary of the pharmacokinetic properties of the natural product mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and the average amount of bioactive compounds in the products. 

Item 4: A brief description of the drug mentioned in the query. Include a list of known names used to refer to the drug. 

Item 5: A summary of the pharmacokinetic properties of the drug mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and standardized dosage of the drug's active ingredient.

Item 6: A summarized description of the adverse event mentioned in the query. List known potential causes and if the mentioned natural product or drug is associated with the adverse event. Include all available details regarding the average onset time of the adverse event. Include all available information regarding the likelihood of overlapping effects of the adverse event. Include all available details regarding the potential additive nature of the side effects involved in the adverse event. 

Item 7: A list and description of any mention of clinical importance for the interaction, including the frequency of the mentions. 

Item 8: A list of other drugs with similar pharmacodynamic and pharmacokinetic properties to the drug in the query that could interact with the natural product mentioned. 

Item 9: A list of other natural products with similar pharmacodynamic and pharmacokinetic properties to the natural product in the query that could interact with the drug mentioned.

Finally, classify how accurate your synthesis was. Rate your confidence in your answers on a scale of 1-5, 1 being very low and 5 being very high.

### Query ###

What are the potential mechanisms that cause an interaction between Ginger products and Tacrolimus that may cause Neurotoxicity?

-------

# Response from LLM:

Item 1:

1. Ginger products contain gingerols and shogaols, which are bioactive compounds that may interact with Tacrolimus, a drug used to prevent organ rejection after a transplant.
2. Gingerols and shogaols may inhibit the metabolism of Tacrolimus, leading to increased levels of the drug in the body.
3. Increased levels of Tacrolimus may cause neurotoxicity, a condition characterized by damage to the nervous system.

Item 2:

Ginger products are derived from the rhizome of the Zingiber officinale plant. It is commonly used as a spice or herbal supplement and can be consumed in various forms, such as fresh, dried, or powdered.

Item 3:

Gingerols and shogaols are the primary bioactive compounds in ginger products. The average amount of gingerols and shogaols in ginger products varies depending on the preparation method and the specific variety of ginger used. For example, fresh ginger contains approximately 1-4% gingerols and 0.1-0.5% shogaols, while dried ginger contains 0.5-2% gingerols and 0.05-0.2% shogaols.

Item 4:

Tacrolimus is an immunosuppressant drug used to prevent organ rejection after a transplant. It is a calcineurin inhibitor that works by inhibiting the activity of calcineurin, an enzyme involved in the activation of T cells.

Item 5:

Tacrolimus is available in various forms, including tablets, capsules, and oral solutions. The standardized dosage of Tacrolimus is typically 0.5-1 mg per day, depending on the specific condition being treated and the patient's response to the drug.

Item 6:

Neurotoxicity is a potential adverse effect of Tacrolimus, which may occur due to increased levels of the drug in the body. The onset time of neurotoxicity is typically within the first few weeks of treatment, and the likelihood of this adverse effect is increased when Tacrolimus levels are elevated.

Item 7:

The potential interaction between ginger products and Tacrolimus may cause neurotoxicity. This interaction has been reported in some cases, but the frequency of this interaction is not well-documented.

Item 8:

Other drugs with similar pharmacodynamic and pharmacokinetic properties to Tacrolimus that could interact with ginger products and cause neurotoxicity include cyclosporine, sirolimus, and everolimus. These drugs are also calcineurin inhibitors and are used to prevent organ rejection after a transplant.

Item 9:

Other natural products with similar pharmacodynamic and pharmacokinetic properties to ginger products that could interact with Tacrolimus and cause neurotoxicity include turmeric, black pepper, and cinnamon. These natural products contain bioactive compounds that may interact with Tacrolimus and increase the risk of neurotoxicity.

Confidence: 3

The confidence in this synthesis is moderate, as there is limited information available on the potential interaction between ginger products and Tacrolimus. However, the information provided suggests that the interaction may cause neurotoxicity and that other drugs with similar properties may also interact with ginger products.